Precision medicine to improve the risk and benefit of cancer care: genetic factors in vincristine-related neuropathy

JAMA. 2015 Feb 24;313(8):803-4. doi: 10.1001/jama.2015.1086.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Agents, Phytogenic / adverse effects*
  • Female
  • Humans
  • Male
  • Microtubule-Associated Proteins / genetics*
  • Peripheral Nervous System Diseases / genetics*
  • Polymorphism, Single Nucleotide*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Vincristine / adverse effects*

Substances

  • Antineoplastic Agents, Phytogenic
  • CEP72 protein, human
  • Microtubule-Associated Proteins
  • Vincristine